Literature DB >> 10088135

The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade.

L Ferraro1, T Antonelli, S Tanganelli, W T O'Connor, M Perez de la Mora, J Mendez-Franco, F A Rambert, K Fuxe.   

Abstract

The effects of modafinil on glutamatergic and GABAergic transmission in the rat medial preoptic area (MPA) and posterior hypothalamus (PH), are analysed. Modafinil (30-300 mg/kg) increased glutamate and decreased GABA levels in the MPA and PH. Local perfusion with the GABAA agonist muscimol (10 microM), reduced, while the GABAA antagonist bicuculline (1 microM and 10 microM) increased glutamate levels. The modafinil (100 mg/kg)-induced increase of glutamate levels was antagonized by local perfusion with bicuculline (1 microM). When glutamate levels were increased by the local perfusion with the glutamate uptake inhibitor L-trans-PDC (0.5 mM), modafinil produced an additional enhancement of glutamate levels. Modafinil (1-33 microM) failed to affect [3H]glutamate uptake in hypothalamic synaptosomes and slices. These findings show that modafinil increases glutamate and decreases GABA levels in MPA and PH. The evidence that bicuculline counteracts the modafinil-induced increase of glutamate levels strengthens the evidence for an inhibitory GABA/glutamate interaction in the above regions controlling the sleep-wakefulness cycle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10088135     DOI: 10.1016/S0893-133X(98)00085-2

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  38 in total

Review 1.  New medications for drug addiction hiding in glutamatergic neuroplasticity.

Authors:  P W Kalivas; N D Volkow
Journal:  Mol Psychiatry       Date:  2011-04-26       Impact factor: 15.992

Review 2.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

3.  Modafinil in sports: ethical considerations.

Authors:  K R Kaufman
Journal:  Br J Sports Med       Date:  2005-04       Impact factor: 13.800

4.  Modafinil for the treatment of cocaine dependence.

Authors:  Ann L Anderson; Malcolm S Reid; Shou-Hua Li; Tyson Holmes; Lynn Shemanski; April Slee; Edwina V Smith; Roberta Kahn; Nora Chiang; Frank Vocci; Domenic Ciraulo; Charles Dackis; John D Roache; Ihsan M Salloum; Eugene Somoza; Harold C Urschel; Ahmed M Elkashef
Journal:  Drug Alcohol Depend       Date:  2009-06-26       Impact factor: 4.492

5.  Probable Nootropicinduced Psychiatric Adverse Effects: A Series of Four Cases.

Authors:  Farid Talih; Jean Ajaltouni
Journal:  Innov Clin Neurosci       Date:  2015 Nov-Dec

6.  Structure-Activity Relationships at the Monoamine Transporters for a Novel Series of Modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) Analogues.

Authors:  Jianjing Cao; Thomas E Prisinzano; Oluyomi M Okunola; Theresa Kopajtic; Matthew Shook; Jonathan L Katz; Amy Hauck Newman
Journal:  ACS Med Chem Lett       Date:  2010-10-10       Impact factor: 4.345

Review 7.  Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder.

Authors:  Gillian M Keating; Michael J Raffin
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

8.  Effects of Modafinil on Clonic Seizure Threshold Induced by Pentylenetetrazole in Mice: Involvement of Glutamate, Nitric oxide, GABA, and Serotonin Pathways.

Authors:  Erfan Bahramnjead; Soheil Kazemi Roodsari; Nastaran Rahimi; Payam Etemadi; Iraj Aghaei; Ahmad Reza Dehpour
Journal:  Neurochem Res       Date:  2018-08-25       Impact factor: 3.996

Review 9.  Controversies in translational research: drug self-administration.

Authors:  Margaret Haney; Roger Spealman
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

Review 10.  Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.

Authors:  José A Apud; Daniel R Weinberger
Journal:  NeuroRx       Date:  2006-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.